A Comparison of XELOX Regimen and EOX Regimen as Neoadjuvant Chemotherapy Regimen for Locally Advanced Gastric Cancer.
Completed
- Conditions
- Locally Advanced Gastric Cancer
- Registration Number
- NCT02192983
- Lead Sponsor
- Tianshu Liu
- Brief Summary
This study is designed to assess what is the better neoadjuvant chemotherapy regimen for patients with initially unresectable locally advanced gastric cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 242
Inclusion Criteria
- more than 2 regional bulky lymph nodes macroscopic tumor type is either the Borrmann type 4 or large type 3 tumor invades adjacent structures (T4b)
Exclusion Criteria
- peritoneal metastasis confirmed by CT scan lung metastasis, liver metastasis, pleural effusion, and/or other distant metastasis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate 6 months after diagnosis
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Shanghai Zhongshan Ethics Committee
🇨🇳Shanghai, Shanghai, China
Shanghai Zhongshan Ethics Committee🇨🇳Shanghai, Shanghai, China